Cannabis Law Report
MAY 24, 2022
The issue in this case is whether an employer, under the workers compensation laws of New York, is required to reimburse a patient for medical marijuana, which was prescribed as a form of pain treatment? 1] [2] The Workers’ Compensation Law also requires that treatment be rendered in accordance with its Medical Treatment Guidelines.
FloridaMarijuana.net
JUNE 22, 2018
A 2004 study demonstrated that cannabinoids “decrease motor activity in the stomach and decrease gastric emptying,” which eases the uncomfortable and painful abdominal cramping; significantly decreasing bathroom visits after a meal. Once you were diagnosed, what treatment was suggested by your doctor? What treatment do you follow now?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Otherside Farms
JANUARY 23, 2019
Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. full – 2004). abst – 2004). Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas (full – 2004). news – 2004).
United Patients Group
FEBRUARY 22, 2023
of cannabis users but has only been described in peer-reviewed journals since 2004, when it was first reported by Australian physicians who were treating a woman with nausea and vomiting that occurred every time she smoked marijuana—but not when she ingested the plant in other ways or took other drugs together with cannabis!
Veriheal
NOVEMBER 30, 2021
For the first time in over 50 years, a federal grant has been allocated for studying psychedelic treatment. Johnson’s work with psychedelics began back in 2004, according to the Johns Hopkins website. In 2014, he developed and published the first research on psychedelic treatment of tobacco addiction.
Cannabis Law Report
JANUARY 23, 2020
852/2004 of the European Parliament and of. Council of 29 April 2004 on the hygiene of food products; Having regard to Regulation (EC) no. 853/2004 of the European Parliament and of. Council of 29 April 2004 laying down specific rules in. 854/2004 of the European Parliament and of the. regulations (EC) no.
Cannabis Law Report
JULY 6, 2021
Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid (GABA) facilitator and glutamate antagonist, an effective treatment for alcoholism. ” About Ehave, Inc. Ehave, Inc.
Expert insights. Personalized for you.
52 
Let's personalize your content